The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy

Antonio Di Biagio; Stefano Rusconi; Angela Marzocchetti; Alessio Signori; Irene Schiavetti; Bianca Bruzzone; Laura Monno; Grazia Punzi; Maria Grazia Colao; Giovanni Penco; Maurizio Zazzi; Andrea De Luca; Andrea Giacometti; Luca Butini; Romana Del Gobbo; Patrizia Bagnarelli; Danilo Tacconi; Giovanni Corbelli; Stefania Zanussi; Franco Maggiolo; Annapaola Callegaro; Leonardo Calza; Maria Carla Re; Raffaele Pristerà; Paola Turconi; Antonella Mandas; Alessandra Pozzo; Nuccia Simeone; Sauro Tini; Alessia Zoncada; Elisabetta Paolini; Giorgio Amadio; Laura Sighinolfi; Giuliano Zuccati; Massimo Morfini; Roberto Manetti; Paola Corsi; Luisa Galli; Massimo Di Pietro; Filippo Bartalesi; Grazia Colao; Andrea Tosti; Maurizio Setti; Michele Trezzi; Paolo Bonfanti; Riccardo Pardelli; Irene Arcidiacono; Alberto Degiuli; Michele De Gennaro; Alessandro Chiodera; Alfredo Scalzini; Loredana Palvarini; Paolo Almi; Giovanni Todaro; Paola Cicconi; Maria Rita Gismondo; Valeria Micheli; Maria Luisa Biondi; Nicola Gianotti; Amedeo Capetti; Paola Meraviglia; Enzo Boeri; Cristina Mussini; Monica Pecorari; Alessandro Soria; Sergio Malandrin; Maurizio Santirocchi; Diego Brustia; Paolo Ravanini; Federico Dal Bello; Nino Romano; Maurizio Mineo; Salvatrice Mancuso; Carlo Calzetti; Renato Maserati; Gaetano Filice; Fausto Baldanti; Daniela Francisci; Giustino Parruti; Ennio Polilli; Daria Sacchini; Chiara Martinelli; Rita Consolini; Linda Vatteroni; Angela Vivarelli; Alessandro Nerli; Lucia Lenzi; Giacomo Magnani; Patrizia Ortolani; Massimo Andreoni; Guido Palamara; Caterina Fimiani; Lucia Palmisano; Simona Di Gaimbenedetto; Manuela Colafigli; Vincenzo Vullo; Ombretta Turriziani; Marco Montano; Cataldo Senatore; Chiara Dentone; Angela Gonnelli; Michele Palumbo; Valeria Ghisetti; Stefano Bonora; Palma Delle Foglie; Cristina Rossi; Paolo Grossi; Elena Seminari; Federica Poletti; Vincenzo Mondino; Marina Malena

doi:10.1002/jmv.24017

The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy

Antonio Di Biagio, Stefano Rusconi, Angela Marzocchetti, Alessio Signori, Irene Schiavetti, Bianca Bruzzone, Laura Monno, Grazia Punzi, Maria Grazia Colao, Giovanni Penco, Maurizio Zazzi, Andrea De Luca, Andrea Giacometti, Luca Butini, Romana Del Gobbo, Patrizia Bagnarelli, Danilo Tacconi, Giovanni Corbelli, Stefania Zanussi, Franco MaggioloAnnapaola Callegaro, Leonardo Calza, Maria Carla Re, Raffaele Pristerà, Paola Turconi, Antonella Mandas, Alessandra Pozzo, Nuccia Simeone, Sauro Tini, Alessia Zoncada, Elisabetta Paolini, Giorgio Amadio, Laura Sighinolfi, Giuliano Zuccati, Massimo Morfini, Roberto Manetti, Paola Corsi, Luisa Galli, Massimo Di Pietro, Filippo Bartalesi, Grazia Colao, Andrea Tosti, Maurizio Setti, Michele Trezzi, Paolo Bonfanti, Riccardo Pardelli, Irene Arcidiacono, Alberto Degiuli, Michele De Gennaro, Alessandro Chiodera, Alfredo Scalzini, Loredana Palvarini, Paolo Almi, Giovanni Todaro, Paola Cicconi, Maria Rita Gismondo, Valeria Micheli, Maria Luisa Biondi, Nicola Gianotti, Amedeo Capetti, Paola Meraviglia, Enzo Boeri, Cristina Mussini, Monica Pecorari, Alessandro Soria, Sergio Malandrin, Maurizio Santirocchi, Diego Brustia, Paolo Ravanini, Federico Dal Bello, Nino Romano, Maurizio Mineo, Salvatrice Mancuso, Carlo Calzetti, Renato Maserati, Gaetano Filice, Fausto Baldanti, Daniela Francisci, Giustino Parruti, Ennio Polilli, Daria Sacchini, Chiara Martinelli, Rita Consolini, Linda Vatteroni, Angela Vivarelli, Alessandro Nerli, Lucia Lenzi, Giacomo Magnani, Patrizia Ortolani, Massimo Andreoni, Guido Palamara, Caterina Fimiani, Lucia Palmisano, Simona Di Gaimbenedetto, Manuela Colafigli, Vincenzo Vullo, Ombretta Turriziani, Marco Montano, Cataldo Senatore, Chiara Dentone, Angela Gonnelli, Michele Palumbo, Valeria Ghisetti, Stefano Bonora, Palma Delle Foglie, Cristina Rossi, Paolo Grossi, Elena Seminari, Federica Poletti, Vincenzo Mondino, Marina Malena

Research output: Contribution to journal › Article › peer-review

Abstract

The factors influencing virological response to first-line combined antiretroviral therapy (cART) in an Italian cohort of HIV-1-infected patients were examined. Eligible patients were those enrolled in a national prospective observational cohort (Antiretroviral Resistance Cohort Analysis), starting first-line cART between 2001 and 2011 and who had at least one follow-up of HIV-1 RNA. The primary endpoint was virological success, defined as the first viral load + cell count, viral subtype, and type of NRTI backbone employed, independent predictors of virological success were higher baseline viral load (≥500,000 vs. 100,000 copies/ml, virologic success was only associated with the use of integrase inhibitors in the first cART regimen. Independent predictors of immunological success were baseline CD4⁺ cell count and wGSS

Original language	English
Pages (from-to)	1-8
Number of pages	8
Journal	Journal of Medical Virology
Volume	86
Issue number	10
DOIs	https://doi.org/10.1002/jmv.24017
Publication status	Published - 2014

Keywords

CD4
Drug regimen
Drug resistance
HIV-1 RNA
N(n)RTI backbone
WGSS

ASJC Scopus subject areas

Virology
Infectious Diseases

Access to Document

10.1002/jmv.24017

Cite this

Di Biagio, A., Rusconi, S., Marzocchetti, A., Signori, A., Schiavetti, I., Bruzzone, B., Monno, L., Punzi, G., Colao, M. G., Penco, G., Zazzi, M., De Luca, A., Giacometti, A., Butini, L., Del Gobbo, R., Bagnarelli, P., Tacconi, D., Corbelli, G., Zanussi, S., ... Malena, M. (2014). The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy. Journal of Medical Virology, 86(10), 1-8. https://doi.org/10.1002/jmv.24017

Di Biagio, A, Rusconi, S, Marzocchetti, A, Signori, A, Schiavetti, I, Bruzzone, B, Monno, L, Punzi, G, Colao, MG, Penco, G, Zazzi, M, De Luca, A, Giacometti, A, Butini, L, Del Gobbo, R, Bagnarelli, P, Tacconi, D, Corbelli, G, Zanussi, S, Maggiolo, F, Callegaro, A, Calza, L, Re, MC, Pristerà, R, Turconi, P, Mandas, A, Pozzo, A, Simeone, N, Tini, S, Zoncada, A, Paolini, E, Amadio, G, Sighinolfi, L, Zuccati, G, Morfini, M, Manetti, R, Corsi, P, Galli, L, Di Pietro, M, Bartalesi, F, Colao, G, Tosti, A, Setti, M, Trezzi, M, Bonfanti, P, Pardelli, R, Arcidiacono, I, Degiuli, A, De Gennaro, M, Chiodera, A, Scalzini, A, Palvarini, L, Almi, P, Todaro, G, Cicconi, P, Gismondo, MR, Micheli, V, Biondi, ML, Gianotti, N, Capetti, A, Meraviglia, P, Boeri, E, Mussini, C, Pecorari, M, Soria, A, Malandrin, S, Santirocchi, M, Brustia, D, Ravanini, P, Dal Bello, F, Romano, N, Mineo, M, Mancuso, S, Calzetti, C, Maserati, R , Filice, G , Baldanti, F, Francisci, D, Parruti, G, Polilli, E, Sacchini, D, Martinelli, C, Consolini, R, Vatteroni, L, Vivarelli, A, Nerli, A, Lenzi, L, Magnani, G, Ortolani, P, Andreoni, M, Palamara, G, Fimiani, C, Palmisano, L, Di Gaimbenedetto, S, Colafigli, M, Vullo, V, Turriziani, O, Montano, M, Senatore, C, Dentone, C, Gonnelli, A, Palumbo, M, Ghisetti, V, Bonora, S, Foglie, PD, Rossi, C, Grossi, P, Seminari, E, Poletti, F, Mondino, V & Malena, M 2014, 'The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy', Journal of Medical Virology, vol. 86, no. 10, pp. 1-8. https://doi.org/10.1002/jmv.24017

@article{9fcb6afe69a345049e146b0accfc1fb9,

title = "The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy",

abstract = "The factors influencing virological response to first-line combined antiretroviral therapy (cART) in an Italian cohort of HIV-1-infected patients were examined. Eligible patients were those enrolled in a national prospective observational cohort (Antiretroviral Resistance Cohort Analysis), starting first-line cART between 2001 and 2011 and who had at least one follow-up of HIV-1 RNA. The primary endpoint was virological success, defined as the first viral load + cell count, viral subtype, and type of NRTI backbone employed, independent predictors of virological success were higher baseline viral load (≥500,000 vs. 100,000 copies/ml, virologic success was only associated with the use of integrase inhibitors in the first cART regimen. Independent predictors of immunological success were baseline CD4+ cell count and wGSS ",

keywords = "CD4, Drug regimen, Drug resistance, HIV-1 RNA, N(n)RTI backbone, WGSS",

author = "{Di Biagio}, Antonio and Stefano Rusconi and Angela Marzocchetti and Alessio Signori and Irene Schiavetti and Bianca Bruzzone and Laura Monno and Grazia Punzi and Colao, {Maria Grazia} and Giovanni Penco and Maurizio Zazzi and {De Luca}, Andrea and Andrea Giacometti and Luca Butini and {Del Gobbo}, Romana and Patrizia Bagnarelli and Danilo Tacconi and Giovanni Corbelli and Stefania Zanussi and Franco Maggiolo and Annapaola Callegaro and Leonardo Calza and Re, {Maria Carla} and Raffaele Prister{\`a} and Paola Turconi and Antonella Mandas and Alessandra Pozzo and Nuccia Simeone and Sauro Tini and Alessia Zoncada and Elisabetta Paolini and Giorgio Amadio and Laura Sighinolfi and Giuliano Zuccati and Massimo Morfini and Roberto Manetti and Paola Corsi and Luisa Galli and {Di Pietro}, Massimo and Filippo Bartalesi and Grazia Colao and Andrea Tosti and Maurizio Setti and Michele Trezzi and Paolo Bonfanti and Riccardo Pardelli and Irene Arcidiacono and Alberto Degiuli and {De Gennaro}, Michele and Alessandro Chiodera and Alfredo Scalzini and Loredana Palvarini and Paolo Almi and Giovanni Todaro and Paola Cicconi and Gismondo, {Maria Rita} and Valeria Micheli and Biondi, {Maria Luisa} and Nicola Gianotti and Amedeo Capetti and Paola Meraviglia and Enzo Boeri and Cristina Mussini and Monica Pecorari and Alessandro Soria and Sergio Malandrin and Maurizio Santirocchi and Diego Brustia and Paolo Ravanini and {Dal Bello}, Federico and Nino Romano and Maurizio Mineo and Salvatrice Mancuso and Carlo Calzetti and Renato Maserati and Gaetano Filice and Fausto Baldanti and Daniela Francisci and Giustino Parruti and Ennio Polilli and Daria Sacchini and Chiara Martinelli and Rita Consolini and Linda Vatteroni and Angela Vivarelli and Alessandro Nerli and Lucia Lenzi and Giacomo Magnani and Patrizia Ortolani and Massimo Andreoni and Guido Palamara and Caterina Fimiani and Lucia Palmisano and {Di Gaimbenedetto}, Simona and Manuela Colafigli and Vincenzo Vullo and Ombretta Turriziani and Marco Montano and Cataldo Senatore and Chiara Dentone and Angela Gonnelli and Michele Palumbo and Valeria Ghisetti and Stefano Bonora and Foglie, {Palma Delle} and Cristina Rossi and Paolo Grossi and Elena Seminari and Federica Poletti and Vincenzo Mondino and Marina Malena",

year = "2014",

doi = "10.1002/jmv.24017",

language = "English",

volume = "86",

pages = "1--8",

journal = "Journal of Medical Virology",

issn = "0146-6615",

publisher = "Wiley-Liss Inc.",

number = "10",

}

TY - JOUR

T1 - The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy

AU - Di Biagio, Antonio

AU - Rusconi, Stefano

AU - Marzocchetti, Angela

AU - Signori, Alessio

AU - Schiavetti, Irene

AU - Bruzzone, Bianca

AU - Monno, Laura

AU - Punzi, Grazia

AU - Colao, Maria Grazia

AU - Penco, Giovanni

AU - Zazzi, Maurizio

AU - De Luca, Andrea

AU - Giacometti, Andrea

AU - Butini, Luca

AU - Del Gobbo, Romana

AU - Bagnarelli, Patrizia

AU - Tacconi, Danilo

AU - Corbelli, Giovanni

AU - Zanussi, Stefania

AU - Maggiolo, Franco

AU - Callegaro, Annapaola

AU - Calza, Leonardo

AU - Re, Maria Carla

AU - Pristerà, Raffaele

AU - Turconi, Paola

AU - Mandas, Antonella

AU - Pozzo, Alessandra

AU - Simeone, Nuccia

AU - Tini, Sauro

AU - Zoncada, Alessia

AU - Paolini, Elisabetta

AU - Amadio, Giorgio

AU - Sighinolfi, Laura

AU - Zuccati, Giuliano

AU - Morfini, Massimo

AU - Manetti, Roberto

AU - Corsi, Paola

AU - Galli, Luisa

AU - Di Pietro, Massimo

AU - Bartalesi, Filippo

AU - Colao, Grazia

AU - Tosti, Andrea

AU - Setti, Maurizio

AU - Trezzi, Michele

AU - Bonfanti, Paolo

AU - Pardelli, Riccardo

AU - Arcidiacono, Irene

AU - Degiuli, Alberto

AU - De Gennaro, Michele

AU - Chiodera, Alessandro

AU - Scalzini, Alfredo

AU - Palvarini, Loredana

AU - Almi, Paolo

AU - Todaro, Giovanni

AU - Cicconi, Paola

AU - Gismondo, Maria Rita

AU - Micheli, Valeria

AU - Biondi, Maria Luisa

AU - Gianotti, Nicola

AU - Capetti, Amedeo

AU - Meraviglia, Paola

AU - Boeri, Enzo

AU - Mussini, Cristina

AU - Pecorari, Monica

AU - Soria, Alessandro

AU - Malandrin, Sergio

AU - Santirocchi, Maurizio

AU - Brustia, Diego

AU - Ravanini, Paolo

AU - Dal Bello, Federico

AU - Romano, Nino

AU - Mineo, Maurizio

AU - Mancuso, Salvatrice

AU - Calzetti, Carlo

AU - Maserati, Renato

AU - Filice, Gaetano

AU - Baldanti, Fausto

AU - Francisci, Daniela

AU - Parruti, Giustino

AU - Polilli, Ennio

AU - Sacchini, Daria

AU - Martinelli, Chiara

AU - Consolini, Rita

AU - Vatteroni, Linda

AU - Vivarelli, Angela

AU - Nerli, Alessandro

AU - Lenzi, Lucia

AU - Magnani, Giacomo

AU - Ortolani, Patrizia

AU - Andreoni, Massimo

AU - Palamara, Guido

AU - Fimiani, Caterina

AU - Palmisano, Lucia

AU - Di Gaimbenedetto, Simona

AU - Colafigli, Manuela

AU - Vullo, Vincenzo

AU - Turriziani, Ombretta

AU - Montano, Marco

AU - Senatore, Cataldo

AU - Dentone, Chiara

AU - Gonnelli, Angela

AU - Palumbo, Michele

AU - Ghisetti, Valeria

AU - Bonora, Stefano

AU - Foglie, Palma Delle

AU - Rossi, Cristina

AU - Grossi, Paolo

AU - Seminari, Elena

AU - Poletti, Federica

AU - Mondino, Vincenzo

AU - Malena, Marina

PY - 2014

Y1 - 2014

N2 - The factors influencing virological response to first-line combined antiretroviral therapy (cART) in an Italian cohort of HIV-1-infected patients were examined. Eligible patients were those enrolled in a national prospective observational cohort (Antiretroviral Resistance Cohort Analysis), starting first-line cART between 2001 and 2011 and who had at least one follow-up of HIV-1 RNA. The primary endpoint was virological success, defined as the first viral load + cell count, viral subtype, and type of NRTI backbone employed, independent predictors of virological success were higher baseline viral load (≥500,000 vs. 100,000 copies/ml, virologic success was only associated with the use of integrase inhibitors in the first cART regimen. Independent predictors of immunological success were baseline CD4+ cell count and wGSS

AB - The factors influencing virological response to first-line combined antiretroviral therapy (cART) in an Italian cohort of HIV-1-infected patients were examined. Eligible patients were those enrolled in a national prospective observational cohort (Antiretroviral Resistance Cohort Analysis), starting first-line cART between 2001 and 2011 and who had at least one follow-up of HIV-1 RNA. The primary endpoint was virological success, defined as the first viral load + cell count, viral subtype, and type of NRTI backbone employed, independent predictors of virological success were higher baseline viral load (≥500,000 vs. 100,000 copies/ml, virologic success was only associated with the use of integrase inhibitors in the first cART regimen. Independent predictors of immunological success were baseline CD4+ cell count and wGSS

KW - CD4

KW - Drug regimen

KW - Drug resistance

KW - HIV-1 RNA

KW - N(n)RTI backbone

KW - WGSS

UR - http://www.scopus.com/inward/record.url?scp=84973861107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973861107&partnerID=8YFLogxK

U2 - 10.1002/jmv.24017

DO - 10.1002/jmv.24017

M3 - Article

VL - 86

SP - 1

EP - 8

JO - Journal of Medical Virology

JF - Journal of Medical Virology

SN - 0146-6615

IS - 10

ER -

The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this